✦ LIBER ✦

Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial

✍ Scribed by Liistro, Francesco; Porto, Italo; Angioli, Paolo; Grotti, Simone; Ducci, Kenneth; Falsini, Giovanni; Bolognese, Leonardo

Book ID: 123396875
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 604 KB
Volume: 166
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.08.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-17: Predilatation With Drug Eluting

TCT-17: Predilatation With Drug Eluting Balloon Followed By Bare Metal Stent Implantation Versus Drug Eluting Stent In The Treatment Of Simple De-Novo Native Coronary Stenosis

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A randomized comparison of drug-eluting

A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

✍ Alfonso, Fernando (author);Pérez-Vizcayno, Maria Jose (author);Cárdenas, Alberto 📂 Article 📅 2014 🏛 Elsevier USA 🌐 English ⚖ 504 KB

Drug Eluting Balloon Releasing Paclitaxe

Drug Eluting Balloon Releasing Paclitaxel for Treatment of Coronary Restenosis in Bare Metal- and Drug Eluting Stents: Twelve-Month Follow-Up Results from the European PEPPER FIM Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Randomized Comparison of Everolimus-Elut

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial

✍ Stone, G. W.; Midei, M.; Newman, W.; Sanz, M.; Hermiller, J. B.; Williams, J.; F 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 436 KB

The SPIRIT V Diabetic Study: A randomize

The SPIRIT V Diabetic Study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions

✍ Eberhard Grube; Bernard Chevalier; Giulio Guagliumi; Peter C. Smits; Marrianne S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB